
Gerty Schreibelt
Nijmegen, GE 6525GA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?
Journal: Journal for immunotherapy of cancer
Published: December 05, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Journal: Research square
Published: November 24, 2025
Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
Journal: Methods in cell biology
Published: March 28, 2024
Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial.
Journal: Frontiers in immunology
Published: January 09, 2024
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency.
Journal: Nature communications
Published: November 22, 2023
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Journal: Nature communications
Published: May 09, 2023
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Journal: Nature communications
Published: May 09, 2023
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Journal: Oncoimmunology
Published: December 16, 2022
Last Updated: 09/26/2026